GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis (original) (raw)

References

• Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC et al. (2006). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201–209.
  Article Google Scholar
• Buess M, Nuyten DS, Hastie T, Nielsen T, Pesich R, Brown PO . (2007). Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer. Genome Biol 8: R191.
  Article Google Scholar
• de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T et al. (2005). Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85: 154–159.
  Article CAS Google Scholar
• Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B et al. (2007). Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13: 3207–3214.
  Article CAS Google Scholar
• Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M . (2007). Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 67: 6477–6483.
  Article CAS Google Scholar
• Goodison S, Yuan J, Sloan D, Kim R, Li C, Popescu NC et al. (2005). The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res 65: 6042–6053.
  Article CAS Google Scholar
• Grote D, Souabni A, Busslinger M, Bouchard M . (2006). Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133: 53–61.
  Article CAS Google Scholar
• Gupta GP, Massague J . (2006). Cancer metastasis: building a framework. Cell 127: 679–695.
  Article CAS Google Scholar
• Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C et al. (2007a). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446: 765–770.
  Article CAS Google Scholar
• Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K et al. (2007b). ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 104: 19506–19511.
  Article CAS Google Scholar
• Hautala LC, Koistinen R, Seppala M, Butzow R, Stenman UH, Laakkonen P et al. (2008). Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer 123: 2279–2284.
  Article CAS Google Scholar
• Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J et al. (2006). Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292–10301.
  Article CAS Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71–96.
  Article Google Scholar
• Jeschke U, Mylonas I, Kunert-Keil C, Dazert E, Shabani N, Werling M et al. (2005). Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep 13: 413–419.
  CAS PubMed Google Scholar
• Johnston SRD, Swanton C . (2006). Handbook of Metastatic Breast Cancer 8th edn Informa Healthcare: London, pp 232.
  Book Google Scholar
• Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537–549.
  Article CAS Google Scholar
• Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ et al. (2008a). GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13: 141–152.
  Article CAS Google Scholar
• Kouros-Mehr H, Kim JW, Bechis SK, Werb Z . (2008b). GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 20: 164–170.
  Article CAS Google Scholar
• Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z . (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127: 1041–1055.
  Article CAS Google Scholar
• Lim KC, Lakshmanan G, Crawford SE, Gu Y, Grosveld F, Engel JD . (2000). GATA3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat Genet 25: 209–212.
  Article CAS Google Scholar
• Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P et al. (2003). Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100: 5974–5979.
  Article CAS Google Scholar
• Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D et al. (2005). Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 65: 11259–11264.
  Article CAS Google Scholar
• Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518–524.
  Article CAS Google Scholar
• Murphy KM . (2005). Fate vs choice: the immune system reloaded. Immunol Res 32: 193–200.
  Article CAS Google Scholar
• Ni H, Dydensborg AB, Herring FE, Basora N, Gagne D, Vachon PH et al. (2005). Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression. Oncogene 24: 6820–6829.
  Article CAS Google Scholar
• Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C et al. (2006). Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. J Clin Oncol 24: 1656–1664.
  Article CAS Google Scholar
• Parikh P, Palazzo JP, Rose LJ, Daskalakis C, Weigel RJ . (2005). GATA-3 expression as a predictor of hormone response in breast cancer. J Am Coll Surg 200: 705–710.
  Article Google Scholar
• Patient RK, McGhee JD . (2002). The GATA family (vertebrates and invertebrates). Curr Opin Genet Dev 12: 416–422.
  Article CAS Google Scholar
• Shabani N, Mylonas I, Kunert-Keil C, Briese V, Janni W, Gerber B et al. (2005). Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases. Anticancer Res 25: 1761–1764.
  CAS PubMed Google Scholar
• Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G . (2000). Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59: 271–278.
  Article CAS Google Scholar
• Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869–10874.
  Article CAS Google Scholar
• Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X et al. (2004). Mutation of GATA3 in human breast tumors. Oncogene 23: 7669–7678.
  Article CAS Google Scholar
• van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536.
  Article CAS Google Scholar
• van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999–2009.
  Article CAS Google Scholar
• Voduc D, Cheang M, Nielsen T . (2008). GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev 17: 365–373.
  Article CAS Google Scholar
• Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671–679.
  Article CAS Google Scholar

Download references